Anavex Life Sciences Corp. (AVXL) stock
AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 28, 2026Score 6/30
$0.59−0.08 (-11.39%)
Close on Nov 20, 2026Market cap $54.83MP/E –Yield –
Anavex Life Sciences price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Anavex Life Sciences's price to book ratio was 0.9× on Nov 11, 2026, against 3.5× a year earlier. Over the last 5 years it ranged from 0.9× to 9.7×, with a median of 4.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.9× | −2.4 |
| 2025 | Dec 31, 2025 | 3.3× | −4.3 |
| 2024 | Dec 31, 2024 | 7.6× | +2.2 |
| 2023 | Dec 29, 2023 | 5.4× | +0.3 |
| 2022 | Dec 30, 2022 | 5.1× | −3.7 |
| 2021 | Dec 31, 2021 | 8.7× | −3.6 |
| 2020 | Dec 31, 2020 | 12.3× | +5.6 |
| 2019 | Dec 31, 2019 | 6.7× | +3.5 |
| 2018 | Dec 31, 2018 | 3.2× | −2.2 |
| 2017 | Dec 29, 2017 | 5.4× | −17.3 |
| 2016 | Dec 30, 2016 | 22.7× | +8.8 |
| 2015 | Dec 31, 2015 | 13.9× | −32.6 |
| 2014 | Dec 31, 2014 | 46.6× | – |
See a number that looks wrong?